Thursday, May 28, 2009

Multiple Sclerosis Patients Benefit From Diabetes Drug

A drug currently FDA-approved for use in diabetes shows some protective effects in the brains of patients with relapsing remitting multiple sclerosis, researchers at the University of Illinois at Chicago College of Medicine report in a study currently available online in the Journal of Neuroimmunology.

Keywords: University of Illinois, pioglitazone, Actos, neuronal survival, clinical trial.

Source Medical News Today
Full text Link: http://www.medicalnewstoday.com/articles/151448.php

Note: Currently in France is running a clinical trial with Pioglitazone for patients with FA.
( http://www.clinicaltrials.gov/ct2/show/NCT00811681?term=friedreich )

No comments:

Post a Comment